A citation-based method for searching scientific literature

Isabel Ortuño-Lizarán, Xavier Sánchez-Sáez, Pedro Lax, Geidy E Serrano, Thomas G Beach, Charles H Adler, Nicolás Cuenca. Ann Neurol 2020
Times Cited: 6







List of co-cited articles
7 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Phosphorylated α-synuclein in the retina is a biomarker of Parkinson's disease pathology severity.
Isabel Ortuño-Lizarán, Thomas G Beach, Geidy E Serrano, Douglas G Walker, Charles H Adler, Nicolás Cuenca. Mov Disord 2018
50
50

Ocular and visual disorders in Parkinson's disease: Common but frequently overlooked.
Merel S Ekker, Sabine Janssen, Klaus Seppi, Werner Poewe, Nienke M de Vries, Thomas Theelen, Jorik Nonnekes, Bastiaan R Bloem. Parkinsonism Relat Disord 2017
43
33

Decreased dopamine in the retinas of patients with Parkinson's disease.
C Harnois, T Di Paolo. Invest Ophthalmol Vis Sci 1990
237
33


Visual System Involvement in Patients with Newly Diagnosed Parkinson Disease.
Alessandro Arrigo, Alessandro Calamuneri, Demetrio Milardi, Enricomaria Mormina, Laura Rania, Elisa Postorino, Silvia Marino, Giuseppe Di Lorenzo, Giuseppe Pio Anastasi, Maria Felice Ghilardi,[...]. Radiology 2017
25
33

Dopaminergic expression of the Parkinsonian gene LRRK2-G2019S leads to non-autonomous visual neurodegeneration, accelerated by increased neural demands for energy.
Samantha Hindle, Farinaz Afsari, Meg Stark, C Adam Middleton, Gareth J O Evans, Sean T Sweeney, Christopher J H Elliott. Hum Mol Genet 2013
41
33

Retina thickness as a marker of neurodegeneration in prodromal lewy body disease.
Jee-Young Lee, Jeeyun Ahn, Sohee Oh, Joo Young Shin, Yu Kyeong Kim, Hyunwoo Nam, Beomseok Jeon. Mov Disord 2020
8
33

Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study.
Alex Iranzo, Eduard Tolosa, Ellen Gelpi, José Luis Molinuevo, Francesc Valldeoriola, Mónica Serradell, Raquel Sanchez-Valle, Isabel Vilaseca, Francisco Lomeña, Dolores Vilas,[...]. Lancet Neurol 2013
367
16

Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography.
Grant D Aaker, Jane S Myung, Joshua R Ehrlich, Mujtaba Mohammed, Claire Henchcliffe, Szilárd Kiss. Clin Ophthalmol 2010
83
16

The function of α-synuclein.
Jacob T Bendor, Todd P Logan, Robert H Edwards. Neuron 2013
366
16


Color discrimination deficits in Parkinson's disease are related to cognitive impairment and white-matter alterations.
Josie-Anne Bertrand, Christophe Bedetti, Ronald B Postuma, Oury Monchi, Daphné Génier Marchand, Thomas Jubault, Jean-François Gagnon. Mov Disord 2012
49
16

A neurodegenerative perspective on mitochondrial optic neuropathies.
Patrick Yu-Wai-Man, Marcela Votruba, Florence Burté, Chiara La Morgia, Piero Barboni, Valerio Carelli. Acta Neuropathol 2016
71
16

Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease.
Ronald B Postuma, Dag Aarsland, Paolo Barone, David J Burn, Christopher H Hawkes, Wolfgang Oertel, Tjalf Ziemssen. Mov Disord 2012
293
16

Premotor Parkinson's disease: concepts and definitions.
Andrew Siderowf, Anthony E Lang. Mov Disord 2012
92
16

Alteration of visual evoked potentials and electroretinograms in Parkinson's disease.
I Gottlob, E Schneider, W Heider, W Skrandies. Electroencephalogr Clin Neurophysiol 1987
95
16

miR-181a/b downregulation exerts a protective action on mitochondrial disease models.
Alessia Indrieri, Sabrina Carrella, Alessia Romano, Alessandra Spaziano, Elena Marrocco, Erika Fernandez-Vizarra, Sara Barbato, Mariateresa Pizzo, Yulia Ezhova, Francesca M Golia,[...]. EMBO Mol Med 2019
27
16

Spatial frequency tuning of the monkey pattern ERG depends on D2 receptor-linked action of dopamine.
M Tagliati, I Bodis-Wollner, I Kovanecz, P Stanzione. Vision Res 1994
44
16

Composition of the GABA(A) receptors of retinal dopaminergic neurons.
S Gustincich, A Feigenspan, W Sieghart, E Raviola. J Neurosci 1999
43
16

The optic nerve: a "mito-window" on mitochondrial neurodegeneration.
Alessandra Maresca, Chiara la Morgia, Leonardo Caporali, Maria Lucia Valentino, Valerio Carelli. Mol Cell Neurosci 2013
58
16

Estimating the direct and indirect costs associated with Parkinson's disease.
Carmen Rodríguez-Blázquez, Maria João Forjaz, Luis Lizán, Silvia Paz, Pablo Martínez-Martín. Expert Rev Pharmacoecon Outcomes Res 2015
29
16

Staging of brain pathology related to sporadic Parkinson's disease.
Heiko Braak, Kelly Del Tredici, Udo Rüb, Rob A I de Vos, Ernst N H Jansen Steur, Eva Braak. Neurobiol Aging 2003
16

Morphological impairments in retinal neurons of the scotopic visual pathway in a monkey model of Parkinson's disease.
Nicolás Cuenca, María-Trinidad Herrero, Antonia Angulo, Emilio de Juan, Gema C Martínez-Navarrete, Salvador López, Carlos Barcia, José Martín-Nieto. J Comp Neurol 2005
40
16

Predominant affection of the blue cone pathway in Parkinson's disease.
B A Haug, R U Kolle, C Trenkwalder, W H Oertel, W Paulus. Brain 1995
76
16

Perimetric and retinal nerve fiber layer findings in patients with Parkinson's disease.
Evangelia E Tsironi, Anna Dastiridou, Andreas Katsanos, Efthymios Dardiotis, Stella Veliki, Gianna Patramani, Fani Zacharaki, Stella Ralli, Georgios M Hadjigeorgiou. BMC Ophthalmol 2012
51
16

Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease.
Jee-Young Lee, Jae Min Kim, Jeeyun Ahn, Han-Joon Kim, Beom S Jeon, Tae Wan Kim. Mov Disord 2014
66
16

OPA1 deficiency associated with increased autophagy in retinal ganglion cells in a murine model of dominant optic atrophy.
Kathryn E White, Vanessa J Davies, Vanessa E Hogan, Malgorzata J Piechota, Philip P Nichols, Douglas M Turnbull, Marcela Votruba. Invest Ophthalmol Vis Sci 2009
63
16

Quantification and characterization of GABA-ergic amacrine cells in the retina of GAD67-GFP knock-in mice.
Christian Albrecht May, Kouichi Nakamura, Fumino Fujiyama, Yuchio Yanagawa. Acta Ophthalmol 2008
20
16

Discriminative power of different nonmotor signs in early Parkinson's disease. A case-control study.
Nico J Diederich, Vannina Pieri, Géraldine Hipp, Olivier Rufra, Sara Blyth, Michel Vaillant. Mov Disord 2010
28
16


Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerization.
Judith Eschbach, Björn von Einem, Kathrin Müller, Hanna Bayer, Annika Scheffold, Bradley E Morrison, K Lenhard Rudolph, Dietmar R Thal, Anke Witting, Patrick Weydt,[...]. Ann Neurol 2015
66
16

Abnormal visual activation in Parkinson's disease patients.
Ellison Fernando Cardoso, Felipe Fregni, Fernanda Martins Maia, Luciano M Melo, João R Sato, Antonio Cesário Cruz, Edno Tales Bianchi, Danilo Botelho Fernandes, Mário Luiz Ribeiro Monteiro, Egberto Reis Barbosa,[...]. Mov Disord 2010
33
16

Visual dysfunction in Parkinson's disease.
Rimona S Weil, Anette E Schrag, Jason D Warren, Sebastian J Crutch, Andrew J Lees, Huw R Morris. Brain 2016
152
16

New Genes Causing Hereditary Parkinson's Disease or Parkinsonism.
Andreas Puschmann. Curr Neurol Neurosci Rep 2017
36
16

Visual signs and symptoms of progressive supranuclear palsy.
Richard A Armstrong. Clin Exp Optom 2011
25
16

Mutant A53T alpha-synuclein induces neuronal death by increasing mitochondrial autophagy.
Vinay Choubey, Dzhamilja Safiulina, Annika Vaarmann, Michal Cagalinec, Przemyslaw Wareski, Malle Kuum, Alexander Zharkovsky, Allen Kaasik. J Biol Chem 2011
173
16

Oculo-Visual Dysfunction in Parkinson's Disease.
R A Armstrong. J Parkinsons Dis 2015
46
16


Colour discrimination impairment is not a reliable early marker of Parkinson's disease.
O Veselá, E Růzicka, R Jech, J Roth, K Stepánková, P Mecír, Z Solano, E Preclíková. J Neurol 2001
17
16

Parkinson's disease.
Lorraine V Kalia, Anthony E Lang. Lancet 2015
16

Interocular asymmetry of foveal thickness in Parkinson disease.
Eric M Shrier, Christopher R Adam, Brian Spund, Sofya Glazman, Ivan Bodis-Wollner. J Ophthalmol 2012
48
16


Effect of levodopa treatment on contrast sensitivity in Parkinson's disease.
C Bulens, J D Meerwaldt, G J Van der Wildt, J B Van Deursen. Ann Neurol 1987
74
16

A rat model of Parkinsonism shows depletion of dopamine in the retina.
Oliver Biehlmaier, Mesbah Alam, Werner J Schmidt. Neurochem Int 2007
26
16

Distorted color discrimination in 'de novo' parkinsonian patients.
T Büttner, W Kuhn, T Müller, T Patzold, K Heidbrink, H Przuntek. Neurology 1995
69
16


Color vision impairment in Parkinson's disease.
Anna Piro, Antonio Tagarelli, Giuseppe Nicoletti, Robert Fletcher, Aldo Quattrone. J Parkinsons Dis 2014
13
16

Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder.
Ronald B Postuma, Jean-François Gagnon, Mélanie Vendette, Catherine Desjardins, Jacques Y Montplaisir. Ann Neurol 2011
163
16

Extrasynaptic release of dopamine in a retinal neuron: activity dependence and transmitter modulation.
M Puopolo, S E Hochstetler, S Gustincich, R M Wightman, E Raviola. Neuron 2001
103
16

Optical Coherence Tomography as a Biomarker for Diagnosis, Progression, and Prognosis of Neurodegenerative Diseases.
Maria Satue, Javier Obis, Maria J Rodrigo, Sofia Otin, Maria I Fuertes, Elisa Vilades, Hector Gracia, Jose R Ara, Raquel Alarcia, Vicente Polo,[...]. J Ophthalmol 2016
43
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.